OpenAlex
PricingAboutJobs
Log inGet started
Work

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Infectious Diseases
DOI: 10.1086/520980
Authors: P. G. Pappas, C. M. F. Rotstein, R. F. Betts, M. Nucci, D. Talwar, J. J. De Waele, J. A. Vazquez, B. F. Dupont, D. L. Horn, L. Ostrosky-Zeichner, A. C. Reboli, B. Suh, R. Digumarti, C. Wu, L. L. Kovanda, L. J. Arnold, D. N. Buell
Institutions: University of Alabama at Birmingham, Hamilton Health Sciences, University of Rochester, Hospital Universitário Clementino Fraga Filho, Government of Uttar Pradesh, Ghent University Hospital, Henry Ford Health, Hôpital Necker-Enfants Malades, Thomas Jefferson University, Cooper University Hospital, Temple University, Nizam's Institute of Medical Sciences, Astellas Pharma (United States)
Language: English

Topic: Antifungal resistance and susceptibility
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: micafungin, caspofungin, invasive candidiasis, candidemia, echinocandins, antifungal drug comparison, dosing regimen, treatment success, mortality, relapse
SDG: Good health and well-being

Open Access status: closed

Funder: Astellas Pharma
OpenAlex ID: W2139043187
FWCI: 40.45
Cites: 30
Cited by: 675
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms